Clinical Experience with Biphasic Insulin Aspart 30 Treatment in Patients with Type 2 Diabetes Poorly Controlled on Oral Antidiabetic Drugs: The Turkish PRESENT Study
Objective: PRESENT is the largest, completed, six-month, multi-national, open-labelled, uncontrolled, observational study of the efficacy and safety of biphasic insulin aspart 30 (BIAsp 30) treatment in clinical practice. We present results from Turkish patients poorly controlled on oral antidiabeti...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Turkiye Klinikleri
2008-05-01
|
Series: | Turkish Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.turkjem.org/eng/yazilar.asp?yaziid=548&sayiid= |